CCNJL

Across TCGA pan-cancer cohorts, CCNJL RNA is linked to patient survival in 30 of 34 cancer types, making it the most broadly survival-associated CCNJL data layer compared with 4 for mutation status and 2 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher CCNJL RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CCNJL expression acts as an unfavorable survival marker, although some lineages such as BLCA and READ show a favorable association.

KIRP, BLCA, and MESO are the cancer types where CCNJL RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Tertile	II,III,IV	0.215	0.708	<.001	122	view →
BLCA	DFS	Tertile	All	0.666	0.434	<.001	116	view →
MESO	OS	Median	All	0.250	0.522	<.001	87	view →
UVM	OS	Tertile	All	0.492	0.960	<.001	83	view →
STAD	DFS	Tertile	II,III,IV	0.257	0.542	.001	82	view →
LGG	OS	Median	All	0.368	0.538	<.001	52	view →
READ	DFS	Median	All	0.683	0.372	.001	42	view →
COAD	OS	Median	III,IV	0.805	0.569	.005	35	view →
SKCM	DFS	Tertile	III,IV	0.118	0.325	.002	35	view →
ESCA	OS	Median	All	0.348	0.602	.003	33	view →
UCEC	DFS	Quartile	All	0.779	0.885	.005	32	view →
LIHC	OS	Quartile	II,III,IV	0.327	0.676	<.001	30	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 30 lineages.

CCNJL–KIRP (DFS)

Open the KIRP breakdown →